FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Lanza

Research Profile

Objects

Chemicals & Drugs

Concepts & Ideas

Disorders

Devices

Drug Delivery Systems

Living Beings

Activities & Behaviors

Image Enhancement

Occupations

Anatomy

Thrombosis

Procedures

Molecular Probe Techniques

Co-author Network

Publications

TOP 3
Kirk K Hou; Gregory M Lanza; Hua Pan; Samuel A Wickline
Melittin derived peptides for nanoparticle based siRNA transfection.
Hua Pan; Susana San Roman; Paul H Schlesinger; Robert D Schreiber; Michael J Scott; John S Allen; Kirk Hou; Grace Hu; Lingzhi Hu; Gregory M Lanza; Jon N Marsh; Jacob W Myerson; Samuel A Wickline
Programmable nanoparticle functionalization for in vivo targeting.
Ryan E Tomlinson; Gregory R Wohl; Gregory M Lanza; Jennifer A McKenzie; Anne H Schmieder; Matthew J Silva
Angiogenesis is required for stress fracture healing in rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Lanza (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kirk K Hou; Gregory M Lanza; Hua Pan; Samuel A Wickline
Melittin derived peptides for nanoparticle based siRNA transfection.
Biomaterials 2013;34(12):3110-9.
2013: Hua Pan; Susana San Roman; Paul H Schlesinger; Robert D Schreiber; Michael J Scott; John S Allen; Kirk Hou; Grace Hu; Lingzhi Hu; Gregory M Lanza; Jon N Marsh; Jacob W Myerson; Samuel A Wickline
Programmable nanoparticle functionalization for in vivo targeting.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(1):255-64.
2013: Ryan E Tomlinson; Gregory R Wohl; Gregory M Lanza; Jennifer A McKenzie; Anne H Schmieder; Matthew J Silva
Angiogenesis is required for stress fracture healing in rats.
Bone 2013;52(1):212-9.
2012: Hui-Fang Zhou; Gregory M Lanza; Dipanjan Pan; Angana Senpan; Samuel A Wickline; Huimin Yan; Christine T N Pham
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.
Biomaterials 2012;33(33):8632-40.
2012: Dipanjan Pan; Nibedita Sanyal; Anne H Schmieder; Angana Senpan; Samuel A Wickline; Xiaoxia Yang; John S Allen; Richard W Gross; Grace Hu; Benjamin Kim; Gregory M Lanza
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
Nanomedicine (London, England) 2012;7(10):1507-19.
2012: Dipanjan Pan; Allen J Stacy; Lihong V Wang; Xin Cai; Benjamin Kim; Gregory M Lanza
Rapid synthesis of near infrared polymeric micelles for real-time sentinel lymph node imaging.
Advanced healthcare materials 2012;1(5):582-9.
2012: Gregory M Lanza
ICAM-1 and nanomedicine: nature's doorway to the extravascular tissue realm.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(5):1070-1.
2012: Dipanjan Pan; Roland Proska; Ewald Roessl; Carsten O Schirra; Anne H Schmieder; Angana Senpan; Allen J Stacy; Axel Thran; Samuel A Wickline; Gregory M Lanza
An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging.
ACS nano 2012;6(4):3364-70.
2012: Dipanjan Pan; Angana Senpan; Lihong V Wang; Samuel A Wickline; Ceren Yalaz; Xin Cai; Karthik Omanakuttan; Gregory M Lanza
Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles.
ACS nano 2012;6(2):1260-7.
2012: Kejia Cai; Shelton D Caruthers; Garry E Kiefer; Gregory M Lanza; Samuel A Wickline; Patrick M Winter
Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles.
NMR in biomedicine 2012;25(2):279-85.
2012: Hua Pan; Paul H Schlesinger; Neelesh R Soman; Eric T Christenson; Olena Ivashyna; Gregory M Lanza; Jon N Marsh; Samuel A Wickline
Postformulation peptide drug loading of nanostructures.
Methods in enzymology 2012;508():17-39.
2011: Dipanjan Pan; Manojit Pramanik; Lihong V Wang; Samuel A Wickline; Gregory M Lanza
Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging.
Contrast media & molecular imaging 2011;6(5):378-88.
2011: Gregory M Lanza
Emerging contrast agents for photoacoustic imaging.
Contrast media & molecular imaging 2011;6(5):331.
2011: Dipanjan Pan; Angana Senpan; Allen J Stacy; Samuel A Wickline; Ceren Yalaz; Shelton D Caruthers; Patrick J Gaffney; Grace Hu; Jon N Marsh; Gregory M Lanza
Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus.
Journal of the American Chemical Society 2011;133(24):9168-71.
2011: Jon N Marsh; Michael J Scott; Samuel A Wickline; Huiying Zhang; Dana Abendschein; Shelton D Caruthers; Patrick J Gaffney; Matthew J Goette; Grace Hu; Gregory M Lanza
A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.
Nanomedicine (London, England) 2011;6(4):605-15.
2011: Hua Pan; Neelesh R Soman; Paul H Schlesinger; Gregory M Lanza; Samuel A Wickline
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2011;3(3):318-27.
2011: Dipanjan Pan; Manojit Pramanik; Angana Senpan; John S Allen; Huiying Zhang; Samuel A Wickline; Lihong V Wang; Gregory M Lanza
Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(3):875-82.
2011: Hua Pan; Olena Ivashyna; Bhaswati Sinha; Gregory M Lanza; Lee Ratner; Paul H Schlesinger; Samuel A Wickline
Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling.
Biomaterials 2011;32(1):231-8.
2011: Franklin D Hockett; Kirk D Wallace; Anne H Schmieder; Shelton D Caruthers; Christine T N Pham; Samuel A Wickline; Gregory M Lanza
Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.
IEEE transactions on medical imaging 2011;30(1):22-7.
2010: Dipanjan Pan; Ewald Roessl; Jens-Peter Schlomka; Shelton D Caruthers; Angana Senpan; Mike J Scott; John S Allen; Huiying Zhang; Grace Hu; Patrick J Gaffney; Eric T Choi; Volker Rasche; Samuel A Wickline; Roland Proksa; Gregory M Lanza
Computed tomography in color: NanoK-enhanced spectral CT molecular imaging.
Angewandte Chemie (International ed. in English) 2010;49(50):9635-9.
2010: Dipanjan Pan; Manojit Pramanik; Angana Senpan; Samuel A Wickline; Lihong V Wang; Gregory M Lanza
A facile synthesis of novel self-assembled gold nanorods designed for near-infrared imaging.
Journal of nanoscience and nanotechnology 2010;10(12):8118-23.
2010: Kent S Boles; Anne H Schmieder; Alexander W Koch; Richard A D Carano; Yan Wu; Shelton D Caruthers; Raymond K Tong; Scott Stawicki; Grace Hu; Michael J Scott; Huiying Zhang; Benton A Reynolds; Samuel A Wickline; Gregory M Lanza
MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(11):4262-70.
2010: Hui-Fang Zhou; Grace Hu; Samuel A Wickline; Gregory M Lanza; Christine T N Pham
Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.
Nanomedicine (London, England) 2010;5(7):1065-74.
2010: Kejia Cai; Shelton D Caruthers; Wenjing Huang; Todd A Williams; Huiying Zhang; Samuel A Wickline; Gregory M Lanza; Patrick M Winter
MR molecular imaging of aortic angiogenesis.
JACC. Cardiovascular imaging 2010;3(8):824-32.
2010: Patrick M Winter; Shelton D Caruthers; John S Allen; Kejia Cai; Todd A Williams; Gregory M Lanza; Samuel A Wickline
Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2010;64(2):369-76.
2010: Gregory M Lanza; Shelton D Caruthers; Patrick M Winter; Michael S Hughes; Anne H Schmieder; Grace Hu; Samuel A Wickline
Angiogenesis imaging with vascular-constrained particles: the why and how.
European journal of nuclear medicine and molecular imaging 2010;37 Suppl 1():S114-26.
2010: Hua Pan; Jacob W Myerson; Olena Ivashyna; Neelesh R Soman; Jon N Marsh; Joshua L Hood; Gregory M Lanza; Paul H Schlesinger; Samuel A Wickline
Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(8):2928-37.
2010: Akers Walter; Zongren Zhang; Mikhail Berezin; Yunpeng Ye; Anthony Agee; Kevin Guo; Ralph W Fuhrhop; Samuel A Wickline; Gregory M Lanza; Samuel achilefu
Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.
Nanomedicine (London, England) 2010;5(5):715-26.
2010: Junjie Chen; Gregory M Lanza; Samuel A Wickline
Quantitative magnetic resonance fluorine imaging: today and tomorrow.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2010;2(4):431-40.
2010: Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; M S Hughes; Grace Hu; Anne H Schmieder; Samuel A Wickline
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.
Angiogenesis 2010;13(2):189-202.
2010: Dipanjan Pan; Manojit Pramanik; Angana Senpan; Soumojit Ghosh; Samuel A Wickline; Lihong V Wang; Gregory M Lanza
Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons.
Biomaterials 2010;31(14):4088-93.
2010: Megan M Kaneda; Yo Sasaki; Gregory M Lanza; Jeffrey Milbrandt; Samuel A Wickline
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.
Biomaterials 2010;31(11):3079-86.
2009: Angana Senpan; Shelton D Caruthers; Ilsu Rhee; Nicholas A Mauro; Dipanjan Pan; Grace Hu; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Conquering the dark side: colloidal iron oxide nanoparticles.
ACS nano 2009;3(12):3917-26.
2009: Michael S Hughes; J E McCarthy; M Victor Wickerhauser; Jon N Marsh; J M Arbeit; Ralph W Fuhrhop; Kirk D Wallace; T Thomas; J Smith; K Agyem; Gregory M Lanza; Samuel A Wickline
Real-time calculation of a limiting form of the Renyi entropy applied to detection of subtle changes in scattering architecture.
The Journal of the Acoustical Society of America 2009;126(5):2350-8.
2009: Joshua L Hood; Hua Pan; Gregory M Lanza; Samuel A Wickline
Paracrine induction of endothelium by tumor exosomes.
Laboratory investigation; a journal of technical methods and pathology 2009;89(11):1317-28.
2009: Dipanjan Pan; Todd A Williams; Angana Senpan; John S Allen; Mike J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle.
Journal of the American Chemical Society 2009;131(42):15522-7.
2009: Megan M Kaneda; Shelton D Caruthers; Gregory M Lanza; Samuel A Wickline
Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
Annals of biomedical engineering 2009;37(10):1922-33.
2009: Neelesh R Soman; Steven L Baldwin; Grace Hu; Jon N Marsh; Gregory M Lanza; John Edward Heuser; Jeffrey M Arbeit; Samuel A Wickline; Paul H Schlesinger
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.
The Journal of clinical investigation 2009;119(9):2830-42.
2009: Hui-Fang Zhou; Happy W Chan; Samuel A Wickline; Gregory M Lanza; Christine T N Pham
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(9):2978-85.
2009: Shelton D Caruthers; Tillmann Cyrus; Patrick M Winter; Samuel A Wickline; Gregory M Lanza
Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2009;1(3):311-23.
2009: M S Hughes; J N Marsh; J M Arbeit; R G Neumann; R W Fuhrhop; K D Wallace; L Thomas; J Smith; K Agyem; Gregory M Lanza; Samuel A Wickline; J E McCarthy
Application of Renyi entropy for ultrasonic molecular imaging.
The Journal of the Acoustical Society of America 2009;125(5):3141-5.
2009: Dipanjan Pan; Gregory M Lanza; Samuel A Wickline; Shelton D Caruthers
Nanomedicine: perspective and promises with ligand-directed molecular imaging.
European journal of radiology 2009;70(2):274-85.
2009: Michal Lijowski; Shelton D Caruthers; Grace Hu; Huiying Zhang; Michael J Scott; Todd Williams; Todd Erpelding; Anne H Schmieder; Garry Kiefer; Gyongyi Gulyas; Phillip S Athey; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
Investigative radiology 2009;44(1):15-22.
2008: Anne M Neubauer; Hoon Sim; Patrick M Winter; Shelton D Caruthers; Todd A Williams; J David Robertson; David Sept; Gregory M Lanza; Samuel A Wickline
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;60(6):1353-61.
2008: Anne H Schmieder; Shelton D Caruthers; Huiying Zhang; Todd A Williams; J David Robertson; Samuel A Wickline; Gregory M Lanza
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(12):4179-89.
2008: Anne M Neubauer; Jacob Myerson; Shelton D Caruthers; Franklin D Hockett; Patrick M Winter; Junjie Chen; Patrick J Gaffney; J David Robertson; Gregory M Lanza; Samuel A Wickline
Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;60(5):1066-72.
2008: Emily A Waters; Junjie Chen; Xiaoxia Yang; Huiying Zhang; Robert Neumann; Andrea Santeford; Jeffrey Arbeit; Gregory M Lanza; Samuel A Wickline
Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;60(5):1232-6.
2008: Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
JACC. Cardiovascular imaging 2008;1(5):624-34.
2008: Kathryn C Partlow; Gregory M Lanza; Samuel A Wickline
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.
Biomaterials 2008;29(23):3367-75.
2008: Patrick M Winter; Anne H Schmieder; Shelton D Caruthers; Jeffery L Keene; Huiying Zhang; Samuel A Wickline; Gregory M Lanza
Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(8):2758-67.
2008: Tillmann Cyrus; Huiying Zhang; John S Allen; Todd A Williams; Grace Hu; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(5):820-6.
2008: Neelesh R Soman; Gregory M Lanza; John M Heuser; Paul H Schlesinger; Samuel A Wickline
Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides.
Nano letters 2008;8(4):1131-6.
2008: Emily A Waters; Junjie Chen; John S Allen; Huiying Zhang; Gregory M Lanza; Samuel A Wickline
Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2008;10():43.
2007: Kirk D Wallace; Jon N Marsh; Steven L Baldwin; Anne M Connolly; Richard M Keeling; Gregory M Lanza; Samuel A Wickline; Michael S Hughes
Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2007;54(11):2291-9.
2007: Jon N Marsh; A Senpan; G Hu; Michael J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
Nanomedicine (London, England) 2007;2(4):533-43.
2007: Michael S Hughes; Jon N Marsh; Kirk D Wallace; Tamara A Donahue; Anne M Connolly; Gregory M Lanza; Samuel A Wickline
Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver.
Ultrasound in medicine & biology 2007;33(8):1236-43.
2007: Michael S Hughes; J E McCarthy; Jon N Marsh; J M Arbeit; R G Neumann; Ralph W Fuhrhop; Kirk D Wallace; D R Znidersic; B N Maurizi; Steven L Baldwin; Gregory M Lanza; Samuel A Wickline
Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging.
The Journal of the Acoustical Society of America 2007;121(6):3542-57.
2007: Jon N Marsh; Kathryn C Partlow; Dana R Abendschein; Michael J Scott; Gregory M Lanza; Samuel A Wickline
Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.
Ultrasound in medicine & biology 2007;33(6):950-8.
2007: Kathryn C Partlow; Junjie Chen; Jason A Brant; Anne M Neubauer; Todd E Meyerrose; Michael H Creer; Jan A Nolta; Shelton D Caruthers; Gregory M Lanza; Samuel A Wickline
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(8):1647-54.
2007: Grace Hu; Michal Lijowski; Huiying Zhang; Kathryn C Partlow; Shelton D Caruthers; Garry E Kiefer; Gyongyi Gulyas; Phillip S Athey; Michael J Scott; Samuel A Wickline; Gregory M Lanza
Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.
International journal of cancer. Journal international du cancer 2007;120(9):1951-7.
2007: Samuel A Wickline; Anne M Neubauer; Patrick M Winter; Shelton D Caruthers; Gregory M Lanza
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
Journal of magnetic resonance imaging : JMRI 2007;25(4):667-80.
2007: Patrick M Winter; Kejia Cai; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
Expert review of medical devices 2007;4(2):137-45.
2007: Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Nanotechnological applications in medicine.
Current opinion in biotechnology 2007;18(1):26-30.
2007: Trung D Tran; Shelton D Caruthers; Michael Hughes; Jon N Marsh; Tillmann Cyrus; Patrick M Winter; Anne M Neubauer; Samuel A Wickline; Gregory M Lanza
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
International journal of nanomedicine 2007;2(4):515-26.
2007: Tillmann Cyrus; Gregory M Lanza; Samuel A Wickline
Molecular imaging by cardiovascular MR.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2007;9(6):827-43.
2007: Anne M Neubauer; Shelton D Caruthers; Franklin D Hockett; Tillmann Cyrus; J David Robertson; John S Allen; Todd D Williams; Ralph W Fuhrhop; Gregory M Lanza; Samuel A Wickline
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2007;9(3):565-73.
2007: Christopher Adair; Mark Woods; Piyu Zhao; Azhar Pasha; Patrick M Winter; Gregory M Lanza; Phillip S Athey; A Dean Sherry; Garry E Kiefer
Spectral properties of a bifunctional PARACEST europium chelate: an intermediate for targeted imaging applications.
Contrast media & molecular imaging 2007;2(1):55-8.
2006: Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;56(6):1384-8.
2006: Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Michael S Hughes; Tillmann Cyrus; Jon N Marsh; Anne M Neubauer; Kathryn C Partlow; Samuel A Wickline
Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Nanomedicine (London, England) 2006;1(3):321-9.
2006: Michael S Hughes; Jon N Marsh; Hyuing Zhang; Adam K Woodson; John S Allen; Elizabeth K Lacy; Cordelia Carradine; Gregory M Lanza; Samuel A Wickline
Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2006;53(9):1609-16.
2006: Patrick M Winter; Anne M Neubauer; Shelton D Caruthers; Thomas D Harris; J David Robertson; Todd A Williams; Anne H Schmieder; Grace Hu; John S Allen; Elizabeth K Lacy; Huiying Zhang; Samuel A Wickline; Gregory M Lanza
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(9):2103-9.
2006: Neelesh R Soman; Jon N Marsh; Michael S Hughes; Gregory M Lanza; Samuel A Wickline
Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity.
IEEE transactions on nanobioscience 2006;5(2):69-75.
2006: Shelton D Caruthers; Anne M Neubauer; Franklin D Hockett; Rolf Lamerichs; Patrick M Winter; Michael J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla.
Investigative radiology 2006;41(3):305-12.
2006: Patrick M Winter; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Molecular imaging by MRI.
Current cardiology reports 2006;8(1):65-9.
2006: Tillmann Cyrus; Dana R Abendschein; Shelton D Caruthers; Thomas D Harris; Veronica Glattauer; Jerome A Werkmeister; John A M Ramshaw; Samuel A Wickline; Gregory M Lanza
MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2006;8(3):535-41.
2006: Shelton D Caruthers; Patrick M Winter; Samuel A Wickline; Gregory M Lanza
Targeted magnetic resonance imaging contrast agents.
Methods in molecular medicine 2006;124():387-400.
2005: Kathryn C Crowder; Michael S Hughes; Jon N Marsh; Alejandro M Barbieri; Ralph W Fuhrhop; Gregory M Lanza; Samuel A Wickline
Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.
Ultrasound in medicine & biology 2005;31(12):1693-700.
2005: Michael S Hughes; Jon N Marsh; Christopher S Hall; David Savéry; Gregory M Lanza; Samuel A Wickline
Characterization of digital waveforms using thermodynamic analogs: applications to detection of materials defects.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2005;52(9):1555-64.
2005: Tillmann Cyrus; Patrick M Winter; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
Expert review of cardiovascular therapy 2005;3(4):705-15.
2005: Patrick M Winter; Himanshu P Shukla; Shelton D Caruthers; Michael J Scott; Ralph W Fuhrhop; J David Robertson; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Molecular imaging of human thrombus with computed tomography.
Academic radiology 2005;12 Suppl 1():S9-13.
2005: Anne H Schmieder; Patrick M Winter; Shelton D Caruthers; Thomas D Harris; Todd A Williams; John S Allen; Elizabeth K Lacy; Huiying Zhang; Michael J Scott; Grace Hu; J David Robertson; Samuel A Wickline; Gregory M Lanza
Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2005;53(3):621-7.
2005: Michael S Hughes; Jon N Marsh; Christopher S Hall; Ralph W Fuhrhop; Elizabeth K Lacy; Gregory M Lanza; Samuel A Wickline
Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.
The Journal of the Acoustical Society of America 2005;117(2):964-72.
2005: Gregory M Lanza; Patrick M Winter; Anne M Neubauer; Shelton D Caruthers; Franklin D Hockett; Samuel A Wickline
1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.
Current topics in developmental biology 2005;70():57-76.
2004: Anne M Morawski; Patrick M Winter; Xin Yu; Ralph W Fuhrhop; Michael J Scott; Franklin D Hockett; J David Robertson; Patrick J Gaffney; Gregory M Lanza; Samuel A Wickline
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;52(6):1255-62.
2004: Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Kathryn C Crowder; Samuel A Wickline
Magnetic resonance molecular imaging with nanoparticles.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2004;11(6):733-43.
2004: Shiow-Jiuan Lin; Peggy A Brown; Mary P Watkins; Todd A Williams; Katherine A Lehr; Wei Liu; Gregory M Lanza; Samuel A Wickline; Shelton D Caruthers
Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound.
Journal of the American College of Cardiology 2004;44(1):133-7.
2004: Jon N Marsh; Shin Takiuchi; Shiow-Jiuan Lin; Gregory M Lanza; Samuel A Wickline
Ultrasonic delineation of aortic microstructure: the relative contribution of elastin and collagen to aortic elasticity.
The Journal of the Acoustical Society of America 2004;115(5 Pt 1):2032-40.
2004: Anne M Morawski; Patrick M Winter; Kathryn C Crowder; Shelton D Caruthers; Ralph W Fuhrhop; Michael J Scott; J David Robertson; Dana R Abendschein; Gregory M Lanza; Samuel A Wickline
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;51(3):480-6.
2004: Jason H Rogers; Shelton D Caruthers; Todd Williams; S J Lin; Deborah Meyers; Gregory M Lanza; Sandor Kovacs; John M Lasala; Samuel A Wickline
Clinical utility of rapid prescreening magnetic resonance angiography of peripheral vascular disease prior to cardiac catheterization.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2004;6(1):25-31.
2003: Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.
Circulation 2003;108(18):2270-4.
2003: Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Cancer research 2003;63(18):5838-43.
2003: Patrick M Winter; Shelton D Caruthers; Xin Yu; Sheng-Kwei Song; Junjie Chen; Brad Miller; Jeff W M Bulte; J David Robertson; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Improved molecular imaging contrast agent for detection of human thrombus.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2003;50(2):411-6.
2002: Jon N Marsh; Christopher S Hall; Samuel A Wickline; Gregory M Lanza
Temperature dependence of acoustic impedance for specific fluorocarbon liquids.
The Journal of the Acoustical Society of America 2002;112(6):2858-62.
2002: Gregory M Lanza; Xin Yu; Patrick M Winter; Dana R Abendschein; Kerry K Karukstis; Michael J Scott; Lori K Chinen; Ralph W Fuhrhop; David E Scherrer; Samuel A Wickline
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
Circulation 2002;106(22):2842-7.
2002: Gregory M Lanza; Dana R Abendschein; Xin Yu; Patrick M Winter; Kerry K Karukstis; Michael J Scott; Ralph W Fuhrhop; David E Scherrer; Samuel A Wickline
Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology.
Academic radiology 2002;9 Suppl 2():S330-1.
2002: Samuel A Wickline; Michael Hughes; Francis C Ngo; Christopher S Hall; Jon N Marsh; Peggy A Brown; John S Allen; Mark D McLean; Michael J Scott; Ralph W Fuhrhop; Gregory M Lanza
Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent.
Academic radiology 2002;9 Suppl 2():S290-3.
2002: Samuel A Wickline; Gregory M Lanza
Molecular imaging, targeted therapeutics, and nanoscience.
Journal of cellular biochemistry. Supplement 2002;39():90-7.
2002: Jon N Marsh; Christopher S Hall; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2002;49(1):29-38.
2001: Sebastian Flacke; S Fischer; Michael J Scott; R J Fuhrhop; J S Allen; M McLean; P Winter; G A Sicard; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.
Circulation 2001;104(11):1280-5.
2001: Christopher S Hall; Jon N Marsh; Michael J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent.
The Journal of the Acoustical Society of America 2001;110(3 Pt 1):1677-84.
2001: Gregory M Lanza; Samuel A Wickline
Targeted ultrasonic contrast agents for molecular imaging and therapy.
Progress in cardiovascular diseases 2001;44(1):13-31.
2000: Christopher S Hall; Jon N Marsh; Michael J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent.
The Journal of the Acoustical Society of America 2000;108(6):3049-57.
2000: Xin Yu; Sheng-Kwei Song; Junjie Chen; Michael J Scott; R J Fuhrhop; Christopher S Hall; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2000;44(6):867-72.
2000: Gregory M Lanza; Dana R Abendschein; Christopher S Hall; Michael J Scott; David E Scherrer; A Houseman; J G Miller; Samuel A Wickline
In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2000;13(6):608-14.
2000: Christopher S Hall; Cuong T Nguyen; Michael J Scott; Gregory M Lanza; Samuel A Wickline
Delineation of the extracellular determinants of ultrasonic scattering from elastic arteries.
Ultrasound in medicine & biology 2000;26(4):613-20.
2000: Gregory M Lanza; Dana R Abendschein; Christopher S Hall; Jon N Marsh; Michael J Scott; David E Scherrer; Samuel A Wickline
Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound.
Investigative radiology 2000;35(4):227-34.
2000: Christopher S Hall; Gregory M Lanza; J H Rose; R J Kaufmann; Ralph W Fuhrhop; S H Handley; Kendall Waters; James G Miller; Samuel A Wickline
Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2000;47(1):75-84.
2000: Christopher S Hall; Michael J Scott; Gregory M Lanza; J G Miller; Samuel A Wickline
The extracellular matrix is an important source of ultrasound backscatter from myocardium.
The Journal of the Acoustical Society of America 2000;107(1):612-9.
1998: Gregory M Lanza; RL Trousil; Kirk D Wallace; J H Rose; Christopher S Hall; Michael J Scott; James G Miller; P R Eisenberg; Patrick J Gaffney; Samuel A Wickline
In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy.
The Journal of the Acoustical Society of America 1998;104(6):3665-72.
1998: Gregory M Lanza; Christine H. Lorenz; SE Fischer; Michael J Scott; W P Cacheris; R J Kaufmann; Patrick J Gaffney; Samuel A Wickline
Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent.
Academic radiology 1998;5 Suppl 1():S173-6; discussion S183-4.
1997: Gregory M Lanza; Michael J Scott; G Davison; Christopher S Hall; D H Christy; James G Miller; Samuel A Wickline
Angiotensin II receptor blockade in Syrian hamster (T0-2) cardiomyopathy does not affect microscopic cardiac material properties: implications for mechanisms of tissue remodeling.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(4):521-9.
1997: Gregory M Lanza; Kirk D Wallace; SE Fischer; D H Christy; Michael J Scott; RL Trousil; W P Cacheris; James G Miller; Patrick J Gaffney; Samuel A Wickline
High-frequency ultrasonic detection of thrombi with a targeted contrast system.
Ultrasound in medicine & biology 1997;23(6):863-70.
1996: Gregory M Lanza; Kirk D Wallace; Michael J Scott; W P Cacheris; D R Abendschein; D H Christy; A M Sharkey; James G Miller; Patrick J Gaffney; Samuel A Wickline
A novel site-targeted ultrasonic contrast agent with broad biomedical application.
Circulation 1996;94(12):3334-40.